Skip to main content
Top
Published in: Infection 4/2022

Open Access 23-02-2022 | Wound Infection | Original Paper

Chronic wounds in Sierra Leone: pathogen spectrum and antimicrobial susceptibility

Authors: Frieder Schaumburg, Jonathan Vas Nunes, Giulia Mönnink, Abdul-Mac Falama, James Bangura, Hanna Mathéron, Amara Conteh, Maxwell Sesay, Aminata Sesay, Martin P. Grobusch

Published in: Infection | Issue 4/2022

Login to get access

Abstract

Purpose

Chronic wounds are frequently caused by, or super-infected with, a broad spectrum of bacteria. To guide treatment, healthcare providers need to know the bacterial spectrum and antimicrobial resistance rates to be anticipated. As these data are largely missing for Sierra Leone, we performed a microbiological study on chronic wound infections.

Methods

Wound swabs were analysed for bacteria using culture-based methods. Antimicrobial susceptibility testing was done with Vitek2® automated system and EUCAST clinical breakpoints. Selected resistance phenotypes were confirmed by molecular methods (e.g. mecA/C) and genotyping.

Results

Of 163 included patients, 156 (95.7%) had a positive wound culture. Pseudomonas aeruginosa (n = 75), Klebsiella pneumoniae (n = 42), Proteus mirabilis (n = 31), Staphylococcus aureus-related complex (n = 31) were predominant. Among Gram-negative rods, resistance rates were high for piperacillin/tazobactam (3–67%), cefotaxime (19–71%), and ciprofloxacin (13–60%). Among isolates of the S. aureus-related complex, 55% were methicillin resistant (CC8, PVL-negative).

Conclusion

The high antimicrobial resistance rates in bacteria from chronic wounds strongly speaks against the use of empirical systemic antibiotic therapy if patients do not show signs of systemic infections, and supports the strategy of local wound care.
Literature
1.
go back to reference O’Neill J. Tackling drug-resistant infections globally: final report and recommendations. The review on antimicrobial resistance. 2016. O’Neill J. Tackling drug-resistant infections globally: final report and recommendations. The review on antimicrobial resistance. 2016.
2.
go back to reference Hamilton D, Bugg I. Improving antimicrobial stewardship in the outpatient department of a district general hospital in Sierra Leone. BMJ Open Qual. 2018;7:e000495.CrossRef Hamilton D, Bugg I. Improving antimicrobial stewardship in the outpatient department of a district general hospital in Sierra Leone. BMJ Open Qual. 2018;7:e000495.CrossRef
3.
go back to reference Bediako-Bowan AAA, Kurtzhals JAL, Mølbak K, Labi AK, Owusu E, Newman MJ. High rates of multi-drug resistant gram-negative organisms associated with surgical site infections in a teaching hospital in Ghana. BMC Infect Dis. 2020;20:890.CrossRef Bediako-Bowan AAA, Kurtzhals JAL, Mølbak K, Labi AK, Owusu E, Newman MJ. High rates of multi-drug resistant gram-negative organisms associated with surgical site infections in a teaching hospital in Ghana. BMC Infect Dis. 2020;20:890.CrossRef
4.
go back to reference Lai PS, Bebell LM, Meney C, Valeri L, White MC. Epidemiology of antibiotic-resistant wound infections from six countries in Africa. BMJ Glob Health. 2017;2:e000475.CrossRef Lai PS, Bebell LM, Meney C, Valeri L, White MC. Epidemiology of antibiotic-resistant wound infections from six countries in Africa. BMJ Glob Health. 2017;2:e000475.CrossRef
5.
go back to reference Müller-Schulte E, Tuo MN, Akoua-Koffi C, Schaumburg F, Becker SL. High prevalence of ESBL-producing Klebsiella pneumoniae in clinical samples from central Côte d’Ivoire. Int J Infect Dis. 2020;91:207–9.CrossRef Müller-Schulte E, Tuo MN, Akoua-Koffi C, Schaumburg F, Becker SL. High prevalence of ESBL-producing Klebsiella pneumoniae in clinical samples from central Côte d’Ivoire. Int J Infect Dis. 2020;91:207–9.CrossRef
6.
go back to reference Olalekan A, Onwugamba F, Iwalokun B, Mellmann A, Becker K, Schaumburg F. High proportion of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae among extended-spectrum β-lactamase-producers in Nigerian hospitals. J Glob Antimicrob Resist. 2020;21:8–12.CrossRef Olalekan A, Onwugamba F, Iwalokun B, Mellmann A, Becker K, Schaumburg F. High proportion of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae among extended-spectrum β-lactamase-producers in Nigerian hospitals. J Glob Antimicrob Resist. 2020;21:8–12.CrossRef
7.
go back to reference Tong SY, Schaumburg F, Ellington MJ, Corander J, Pichon B, Leendertz F, et al. Novel staphylococcal species that form part of a Staphylococcus aureus-related complex: the non-pigmented Staphylococcus argenteus sp. nov. and the non-human primate-associated Staphylococcus schweitzeri sp. nov. Int J Syst Evol Microbiol. 2015;65:15–22.CrossRef Tong SY, Schaumburg F, Ellington MJ, Corander J, Pichon B, Leendertz F, et al. Novel staphylococcal species that form part of a Staphylococcus aureus-related complex: the non-pigmented Staphylococcus argenteus sp. nov. and the non-human primate-associated Staphylococcus schweitzeri sp. nov. Int J Syst Evol Microbiol. 2015;65:15–22.CrossRef
8.
go back to reference European Society of Clinical Microbiology and Infectious Diseases. The European Committee on Antimicrobial Susceptibility Testing. Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST, Version 11.0. 2021. https://www.eucast.org/clinical_breakpoints/ European Society of Clinical Microbiology and Infectious Diseases. The European Committee on Antimicrobial Susceptibility Testing. Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST, Version 11.0. 2021. https://​www.​eucast.​org/​clinical_​breakpoints/​
9.
go back to reference Mellmann A, Friedrich AW, Rosenkötter N, Rothgänger J, Karch H, Reintjes R, et al. Automated DNA sequence-based early warning system for the detection of methicillin-resistant Staphylococcus aureus outbreaks. PLoS Med. 2006;3:e33.CrossRef Mellmann A, Friedrich AW, Rosenkötter N, Rothgänger J, Karch H, Reintjes R, et al. Automated DNA sequence-based early warning system for the detection of methicillin-resistant Staphylococcus aureus outbreaks. PLoS Med. 2006;3:e33.CrossRef
10.
go back to reference Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol. 2000;38:1008.CrossRef Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol. 2000;38:1008.CrossRef
11.
go back to reference Strauss L, Stegger M, Akpaka PE, Alabi A, Breurec S, Coombs G, et al. Origin, evolution, and global transmission of community-acquired Staphylococcus aureus ST8. Proc Natl Acad Sci USA. 2017;114:E10596–604.CrossRef Strauss L, Stegger M, Akpaka PE, Alabi A, Breurec S, Coombs G, et al. Origin, evolution, and global transmission of community-acquired Staphylococcus aureus ST8. Proc Natl Acad Sci USA. 2017;114:E10596–604.CrossRef
12.
go back to reference Zingue D, Bouam A, Tian RBD, Drancourt M. Buruli ulcer, a prototype for ecosystem-related infection, caused by Mycobacterium ulcerans. Clin Microbiol Rev. 2018;31:e00045-e117.CrossRef Zingue D, Bouam A, Tian RBD, Drancourt M. Buruli ulcer, a prototype for ecosystem-related infection, caused by Mycobacterium ulcerans. Clin Microbiol Rev. 2018;31:e00045-e117.CrossRef
13.
go back to reference Kpeli G, Yeboah-Manu D. Secondary infection of buruli ulcer lesions. In: Pluschke G, Röltgen K, editors. Buruli ulcer: mycobacterium ulcerans disease. Cham: Springer; 2019. Kpeli G, Yeboah-Manu D. Secondary infection of buruli ulcer lesions. In: Pluschke G, Röltgen K, editors. Buruli ulcer: mycobacterium ulcerans disease. Cham: Springer; 2019.
14.
go back to reference Krumkamp R, Oppong K, Hogan B, Strauss R, Frickmann H, Wiafe-Akenten C, et al. Spectrum of antibiotic resistant bacteria and fungi isolated from chronically infected wounds in a rural district hospital in Ghana. PLoS ONE. 2020;15:e0237263.CrossRef Krumkamp R, Oppong K, Hogan B, Strauss R, Frickmann H, Wiafe-Akenten C, et al. Spectrum of antibiotic resistant bacteria and fungi isolated from chronically infected wounds in a rural district hospital in Ghana. PLoS ONE. 2020;15:e0237263.CrossRef
15.
go back to reference Ramos JM, Pérez-Tanoira R, García-García C, Prieto-Pérez L, Bellón MC, Mateos F, et al. Leprosy ulcers in a rural hospital of Ethiopia: pattern of aerobic bacterial isolates and drug sensitivities. Ann Clin Microbiol Antimicrob. 2014;13:47.CrossRef Ramos JM, Pérez-Tanoira R, García-García C, Prieto-Pérez L, Bellón MC, Mateos F, et al. Leprosy ulcers in a rural hospital of Ethiopia: pattern of aerobic bacterial isolates and drug sensitivities. Ann Clin Microbiol Antimicrob. 2014;13:47.CrossRef
16.
go back to reference Moirongo RM, Lorenz E, Ntinginya NE, Dekker D, Fernandes J, Held J, et al. Regional variation of extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales, fluoroquinolone-resistant Salmonella enterica and methicillin-resistant Staphylococcus aureus among febrile patients in sub-saharan Africa. Front Microbiol. 2020;11:567235.CrossRef Moirongo RM, Lorenz E, Ntinginya NE, Dekker D, Fernandes J, Held J, et al. Regional variation of extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales, fluoroquinolone-resistant Salmonella enterica and methicillin-resistant Staphylococcus aureus among febrile patients in sub-saharan Africa. Front Microbiol. 2020;11:567235.CrossRef
17.
go back to reference Castanheira M, Simner PJ, Bradford PA. Extended-spectrum β-lactamases: an update on their characteristics, epidemiology and detection. JAC Antimicrob Resist. 2021;3:dlab092.CrossRef Castanheira M, Simner PJ, Bradford PA. Extended-spectrum β-lactamases: an update on their characteristics, epidemiology and detection. JAC Antimicrob Resist. 2021;3:dlab092.CrossRef
18.
go back to reference Abdulgader SM, Shittu AO, Nicol MP, Kaba M. Molecular epidemiology of Methicillin-resistant Staphylococcus aureus in Africa: a systematic review. Front Microbiol. 2015;6:348.CrossRef Abdulgader SM, Shittu AO, Nicol MP, Kaba M. Molecular epidemiology of Methicillin-resistant Staphylococcus aureus in Africa: a systematic review. Front Microbiol. 2015;6:348.CrossRef
19.
go back to reference Barogui YT, Klis S, Bankolé HS, Sopoh GE, Mamo S, Baba-Moussa L, et al. Towards rational use of antibiotics for suspected secondary infections in Buruli ulcer patients. PLoS Negl Trop Dis. 2013;7:e2010.CrossRef Barogui YT, Klis S, Bankolé HS, Sopoh GE, Mamo S, Baba-Moussa L, et al. Towards rational use of antibiotics for suspected secondary infections in Buruli ulcer patients. PLoS Negl Trop Dis. 2013;7:e2010.CrossRef
20.
go back to reference Tops SCM, Kolmus M, Wulms D, van Ingen J, Wertheim HFL, Kolwijck E. Recovery of aerobic gram-negative bacteria from the Copan Eswab transport system after long-term storage. Diagn Microbiol Infect Dis. 2020;98:115100.CrossRef Tops SCM, Kolmus M, Wulms D, van Ingen J, Wertheim HFL, Kolwijck E. Recovery of aerobic gram-negative bacteria from the Copan Eswab transport system after long-term storage. Diagn Microbiol Infect Dis. 2020;98:115100.CrossRef
Metadata
Title
Chronic wounds in Sierra Leone: pathogen spectrum and antimicrobial susceptibility
Authors
Frieder Schaumburg
Jonathan Vas Nunes
Giulia Mönnink
Abdul-Mac Falama
James Bangura
Hanna Mathéron
Amara Conteh
Maxwell Sesay
Aminata Sesay
Martin P. Grobusch
Publication date
23-02-2022
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 4/2022
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-022-01762-6

Other articles of this Issue 4/2022

Infection 4/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine